FSB Medical
ActiveSummary
FSB Medical has been active since 2020 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show negative equity (€-424k) and a net result of €-46k. Equity is shrinking by ~12.5% per year across the filed fiscal years. Its solvency ranks better than 5% of 16546 sector peers (fiscal year 2025). The computed 12-month bankruptcy probability is 0.4% (very low).
Checked score
Score 2025
44
/ 100
Weak
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Negative equity caps the score. Every signal that weighs is under Signals.
Axes · tick = 2024
Profitability61▼-3
Solvency0=
Growth58=
Track record100
Bankruptcy probability, 12 months
0.4%
Very low
0%0.5%1.5%4%10%≥ 25%
No credit on open account
Liquidity short (current ratio 0.21 against 0.14 in 2024; short-term debt: 61.6% and cash: 10.4% of total assets), and equity is negative.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025Solvency, return and age of the figures
Solvency
-53.6%
Return on assets
-5.9%
Age of the figures
9 mo
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025Equity per financial year
202122232425
2020 to 2025 · latest year €-424k
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 31-08-2026, 31 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 6 filingsDeviation from the deadline
2025
31 d late
2024
9 d early
2023
30 d late
2022
32 d late
2021
76 d late
2020
31 d late
← before the deadline
after the deadline →
Checked, nothing found (2)
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
24-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, micro schema
Equity
€-424k▼ 12.3%
2024 · €-377k
2020: €-66k
2021: €-257k
2022: €-338k
2023: €-342k
2024: €-377k
2020 → 2025
Total assets
€791k▼ 11.1%
2024 · €889k
2020: €658k
2021: €1.08M
2022: €1.01M
2023: €1.03M
2024: €889k
2020 → 2025
Net result
€-46k▼ 32.1%
2024 · €-35k
2020: €-86k
2021: €-192k
2022: €-81k
2023: €-4k
2024: €-35k
2020 → 2025
Working capital
€-387k▼ 1.8%
2024 · €-380k
2020: €-137k
2021: €-327k
2022: €-414k
2023: €-376k
2024: €-380k
2020 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€-257k-€-338k▼ 31.5%€-342k▼ 1.1%€-377k▼ 10.2%€-424k▼ 12.3%
Operating result€-178k-€-72k▲ 59.3%€9k€-23k€-36k▼ 55.0%
Net result€-192k-€-81k▲ 57.7%€-4k▲ 95.3%€-35k▼ 830%€-46k▼ 32.1%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result stays negative: a loss of €36k in 2025 against €23k in 2024; the loss grows.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €791k
Fixed assets
€691k ▼ 16.7%
Current assets
€100k ▲ 66.9%
Key figures and ratios
EBITDA
€104k▼
2024 · €116k
Cash flow
€93k▼
2024 · €104k
Solvency
-53.6%▼
2024 · -42.4%
Current ratio
0.21▲
2024 · 0.14
Debt to equity
-2.87▲
2024 · -3.36
ROA
-5.9%▼
2024 · -3.9%
Interest coverage
10.13▲
2024 · 9.81
Debt
€1.21M▼
2024 · €1.27M
Debt ≤ 1 year
€487k▲
2024 · €440k
Debt > 1 year
€667k▼
2024 · €786k
Staff costs
€109k▼
2024 · €109k
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet
Code20242025
Assets
Total assets20/58€889k€791k▼
Fixed assets21/28€829k€691k▼
Tangible fixed assets22/27€829k€691k▼
Land and buildings22€645k€603k▼
Plant, machinery and equipment23€159k€75k▼
Furniture and vehicles24€26k€12k▼
Current assets29/58€60k€100k▲
Cash at bank and in hand54/58€37k€82k▲
Deferred charges and accrued income490/1€23k€18k▼
Equity and liabilities
Total equity and liabilities10/49€889k€791k▼
Equity10/15€-377k€-424k▼
Contributions10/11€20k€20k=
Profit (loss) carried forward14€-397k€-444k▼
Amounts payable17/49€1.27M€1.21M▼
Amounts payable after more than one year17€786k€667k▼
Financial debts170/4€786k€667k▼
Amounts payable within one year42/48€440k€487k▲
Current portion of amounts payable after more than one year42€117k€119k▲
Trade debts44€31k€44k▲
Suppliers440/4€31k€44k▲
Taxes, remuneration and social security45€13k€10k▼
Taxes450/3€132€416▲
Remuneration and social security454/9€13k€9k▼
Other amounts payable47/48€279k€315k▲
Accrued charges and deferred income492/3€40k€60k▲
Income statement
Code20242025
Remuneration, social security and pensions62€109k€109k▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€140k€140k▲
Other operating charges640/8€35k€25k▼
Gross operating margin9900€260k€237k▼
Operating profit (loss)9901€-23k€-36k▼
Financial income75/76B€127€81▼
Recurring financial income75€127€81▼
Financial charges65/66B€12k€10k▼
Recurring financial charges65€12k€10k▼
Profit (loss) for the period before taxes9903€-35k€-46k▼
Profit (loss) for the period9904€-35k€-46k▼
Profit (loss) for the period to be appropriated9905€-35k€-46k▼
Appropriation of the result
Profit (loss) to be appropriated9906€-397k€-444k▼
Profit (loss) brought forward from the previous period14P€-362k€-397k▼
The notes to these accounts (15 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
31-08
NBB filing
Annual accounts filed
fiscal year 2025 · micro schema · 31 days late
2025
22-07
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
30-08
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema · 30 days late
2023
01-09
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema · 32 days late
2022
15-10
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema · 76 days late
2021
31-12
Financial
Weakest financial yearnet €-192k
Net result drops to €-192k, the lowest in the series; recovery starts the following year.
31-08
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema · 31 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts
We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Ukkel · 1 establishment unit since 2020
Ground area
1,857 m²
Building footprint
2,479 m²
Volume, LiDAR
57,557 m³
Parcel 21612C0045/00D002, Brussels · tallest building 40.1 m, ±8 floors. Linked by address, not a title deed.
1 establishment unit
FSB Medical
since 20202.318.495.780
1 parcel
Brussels
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 21612C0045/00D002 | Brussels | 1,857 m² | 1 · 2,479 m² | 40.1 m · 8 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector and region
3D DENTAL
BE 0763.853.224
Ukkel
4D DENTAL
BE 0543.835.646
Ukkel
AJRA DENT CLINIC
BE 0771.402.990
Ukkel
AMAND LAURENCE
BE 0465.575.749
Ukkel
ASMILE
BE 0779.459.930
Ukkel
This company's figures show no positive equity and no headcount, so a size comparison is not possible. These companies share only the sector and the region. Of 6,942 companies in sector 86230 we hold annual accounts for 4,291. See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded19-03-2020
Fiscal year end31-12
Activities, NACEBEL 2025
86230Dental practice
Sources
Crossroads Bank for EnterprisesNational Bank · 6 filingsAddress and cadastre registers
Scores and ratios are computed by Checked and are not a credit decision.